Reading speed improvements in retinal vein occlusion after ranibizumab treatment

JAMA Ophthalmology

Volumn 131, Issue 7, 2013, Pages 851-856

  Suñer, Ivan J ^a   Bressler, Neil M ^b   Varma, Rohit ^c   Lee, Paul ^d   Dolan, Chantal M ^e   Ward, James ^e   Colman, Shoshana ^e   Rubio, Roman G ^e  

^a Retina Associates of Florida   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^d DUKE UNIVERSITY EYE CENTER   (United States)

^e GENENTECH INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RANIBIZUMAB;

ADULT; ARTICLE; BRANCH RETINAL VEIN OCCLUSION; CENTRAL RETINA VEIN OCCLUSION; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; LASER SURGERY; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; READING; READING SPEED; RETINA MACULA EDEMA; RETINA VEIN OCCLUSION; TREATMENT OUTCOME; VISUAL ACUITY;

AGED; ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL, HUMANIZED; DOUBLE-BLIND METHOD; FEMALE; HUMANS; INTRAVITREAL INJECTIONS; MACULAR EDEMA; MALE; READING; RETINAL VEIN OCCLUSION; TREATMENT OUTCOME; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VISUAL ACUITY;

EID: 84880253279     PISSN: 21686165     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamaophthalmol.2013.114     Document Type: Article

References (31)

1. Coscas G, Loewenstein A, Augustin A, et al. Management of retinal vein occlusion-consensus document. Ophthalmologica. 2011;226(1):4-28.
2. Ehlers JP, Fekrat S. Retinal vein occlusion: beyond the acute event. Surv Ophthalmol. 2011;56(4):281-299.
3. Rehak M, Wiedemann P. Retinal vein thrombosis: pathogenesis and management. J Thromb Haemost. 2010;8(9):1886-1894.
4. Hayreh SS. Retinal vein occlusion. Indian J Ophthalmol. 1994;42(3):109-132.
5. London NJ, Brown G. Update and review of central retinal vein occlusion. Curr Opin Ophthalmol. 2011;22(3):159-165.
6. Rehak J, Rehak M. Branch retinal vein occlusion: pathogenesis, visual prognosis, and treatment modalities. Curr Eye Res. 2008;33(2):111-131.
7. Gutman FA, Zegarra H. Macular edema secondary to occlusion of the retinal veins. Surv Ophthalmol. 1984;28(Suppl):462-470.
8. Brown DM, Campochiaro PA, Singh RP, et al; CRUISE Investigators. Ranibizumab for macular edema following central retinal vein occlusion: six-month primary end point results of a phase III study. Ophthalmology. 2010;117(6): 1124-1133.
9. Campochiaro PA, Heier JS, Feiner L, et al; BRAVO Investigators. Ranibizumab for macular edema following branch retinal vein occlusion: six-month primary end point results of a phase III study. Ophthalmology. 2010;117(6): 1102-1112.
10. Awdeh RM, Elsing SH, Deramo VA, Stinnett S, Lee PP, Fekrat S. Vision-related quality of life in persons with unilateral branch retinal vein occlusion using the 25-item National Eye Institute Visual Function Questionnaire. Br J Ophthalmol. 2010;94(3):319-323.
11. Deramo VA, Cox TA, Syed AB, Lee PP, Fekrat S. Vision-related quality of life in people with central retinal vein occlusion using the 25-item National Eye Institute Visual Function Questionnaire. Arch Ophthalmol. 2003;121(9):1297-1302.
12. Varma R, Bressler NM, Suñer I, et al; BRAVO and CRUISE Study Groups. Improved vision-related function after ranibizumab for macular edema after retinal vein occlusion: results from the BRAVO and CRUISE trials. Ophthalmology. 2012;119(10): 2108-2118.
13. Crossland MD, Culham LE, Rubin GS. Predicting reading fluency in patients with macular disease. OptomVis Sci. 2005;82(1):11-17.
14. Wolffsohn JS, Cochrane AL. The changing face of the visually impaired: the Kooyong low vision clinic's past, present, and future. OptomVis Sci. 1999;76(11):747-754.
15. Mangione CM, Berry S, Spritzer K, et al. Identifying the content area for the 51-item National Eye Institute Visual Function Questionnaire: results from focus groups with visually impaired persons. Arch Ophthalmol. 1998;116(2):227-233.
16. Elliott DB, Patla A, BullimoreMA. Improvements in clinical and functional vision and perceived visual disability after first and second eye cataract surgery. Br J Ophthalmol. 1997;81(10): 889-895.
17. Hazel CA, Petre KL, Armstrong RA, Benson MT, Frost NA. Visual function and subjective quality of life compared in subjects with acquired macular disease. Invest Ophthalmol Vis Sci. 2000;41(6): 1309-1315.
18. Ahn SJ, Legge GE, Luebker A. Printed cards for measuring low-vision reading speed. Vision Res. 1995;35(13):1939-1944.
19. Owsley C, McGwin G. Measuring the personal burden of eye disease and vision impairment. Ophthalmic Epidemiol. 2007;14(4):188-191.
20. Mangione CM, Lee PP, Gutierrez PR, Spritzer K, Berry S, Hays RD; National Eye Institute Visual Function Questionnaire Field Test Investigators. Development of the 25-item National Eye Institute Visual Function Questionnaire. Arch Ophthalmol. 2001;119(7):1050-1058.
21. Friedman SM, Munoz B, Rubin GS, West SK, Bandeen-Roche K, Fried LP; Salisbury Eye Evaluation Project Team. Characteristics of discrepancies between self-reported visual function and measured reading speed. Invest Ophthalmol Vis Sci. 1999;40(5):858-864.
22. Elliott DB, Patel B, Whitaker D. Development of a reading speed test for potential-vision measurements. Invest Ophthalmol Vis Sci. 2001;42(8):1945-1949.
23. Ergun E, Maár N, RadnerW, Barbazetto I, Schmidt-Erfurth U, Stur M. Scotoma size and reading speed in patients with subfoveal occult choroidal neovascularization in age-related macular degeneration. Ophthalmology. 2003;110(1):65-69.
24. Legge GE, Rubin GS, Pelli DG, Schleske MM. Psychophysics of reading, II: low vision. Vision Res. 1985;25(2):253-265.
25. Brown DM, Campochiaro PA, Bhisitkul RB, et al. Sustained benefits from ranibizumab for macular edema following branch retinal vein occlusion: 12-month outcomes of a phase III study. Ophthalmology. 2011;118(8):1594-1602.
26. Campochiaro PA, Brown DM, Awh CC, et al. Sustained benefits from ranibizumab for macular edema following central retinal vein occlusion: twelve-month outcomes of a phase III study. Ophthalmology. 2011;118(10):2041- 2049.
27. Macular Photocoagulation Study Group. Laser photocoagulation of subfoveal neovascular lesions in age-related macular degeneration: results of a randomized clinical trial. Arch Ophthalmol. 1991;109(9):1220-1231.
28. Cahill MT, Banks AD, Stinnett SS, Toth CA. Vision-related quality of life in patients with bilateral severe age-related macular degeneration. Ophthalmology. 2005;112(1):152-158.
29. Submacular Surgery Trials (SST) Manual of Procedures. Springfield, VA: National Technical Information Service; 1998. NTIS accession No. PB98-166648.
30. Carver PR. Reading Rate: A Review of Research and Theory. San Diego, CA: Academic Press; 1990.
31. Everatt J, Underwood G. Individual differences in reading subprocesses: relationships between reading ability, lexical access, and eyemovement control. Lang Speech. 1994;37(Pt 3):283-297.